Flash Alert: Sell BEAM

Two days ago, we locked in 300%+ profits in Intellia Therapeutics (NTLA). Today, we're taking advantage and locking in even bigger profits in Beam Therapeutics (BEAM).
  Early Stage Investor  
Flash Alert

Jun 30, 2021

Lock in Big Gains in BEAM

Hi Savio,

Two days ago, we locked in 300%+ profits in Intellia Therapeutics (NTLA) as good news caused it and most gene therapy stocks to surge. Today, we’re taking advantage and locking in even bigger profits in Beam Therapeutics (BEAM).

Beam is up more than 330% for us in just a little over eight months, which is huge. The stock is up nearly 20% again today and over 40% just this week on the back of the groundbreaking news from Intellia.

Beam is in the same gene therapy trend, but it does take a different approach than Intellia. More importantly, it is still years away from any potential treatment. That means now is a great time to take our juicy profits.

Let me be clear that I am not saying Beam does not have a bright future. It does, and it could again be a great investment at the right price. For now, we are sitting on big profits, and we know that there will be a lot of volatility in the years ahead for gene therapy stocks and especially Beam due to its early stage development of a treatment.

Sell BEAM and enjoy the gains. It’s been a great week for us!

Sincerely,

Signed:
Matt McCall
Editor, Early Stage Investor

Jun 30, 2021 13:25:49.754

CUSTOMER SERVICE

You can reach us via the following e-mail address: Feedback@InvestorPlace.com or by calling us at 1-800-219-8592.

Copyright © 2021

InvestorPlace Media LLC
1125 N. Charles St,
Baltimore, MD 21201

All rights reserved.

No portion of the above message may be republished, retransmitted or forwarded without express written consent from InvestorPlace Media LLC. Violation of this copyright may result in service cancellation and/or collection of full or partial subscription charges from unauthorized users. Use and/or reliance on this service is strictly at the subscriber’s own risk. InvestorPlace Media LLC will not be liable for the acts or omissions of any third party with regards to delay or non-delivery of Inner Circle. InvestorPlace Media LLC shall not be liable for incidental, indirect, special or consequential damages or for lost profits, savings or revenues of any kind.


Thank you for subscribing to InvestorPlace.com. Please note that we cannot be liable for any missed bulletins caused by overzealous spam filters. To ensure that you continue to receive this valuable part of your service please take a moment to add (customerservice@exct.investorplace.com) to your address book.


Comments

Popular posts from this blog

Can the S&P Surge 20%?

The Most Loved AI Stock Is About to Crash & Burn ❤️‍🔥